Détails du produit
Synonyms
Nucleocapsid protein, NP, Protein N
Source
SARS-CoV-2 Nucleocapsid Protein CTD, His Tag (NUN-C5145) is expressed from E. coli cells. It contains AA Ser 255 - Pro 364 (Accession # QHO62115.1).
Predicted N-terminus: Met
Request for sequenceMolecular Characterization

Other Tags and Version Biotin & Other Labeled Version
This protein carries a polyhistidine tag at the N-terminus.
The protein has a calculated MW of 13.4 kDa. The protein migrates as 15 kDa under reducing (R) condition (SDS-PAGE).
Purity
>95% as determined by SDS-PAGE.
>90% as determined by SEC-MALS.
Formulation
Lyophilized from 0.22 μm filtered solution in PBS, pH7.4 with trehalose as protectant.
Contact us for customized product form or formulation.
Reconstitution
Please see Certificate of Analysis for specific instructions.
For best performance, we strongly recommend you to follow the reconstitution protocol provided in the CoA.
Shipping and Storage
This product is shipped at ambient temperature.
For long term storage, the product should be stored at lyophilized state at -20°C or lower.
Please avoid repeated freeze-thaw cycles.
This product is stable after storage at:
- -20°C to -70°C for 12 months in lyophilized state;
- -70°C for 3 months under sterile conditions after reconstitution.
ACRO Quality Management System
Les clients ont également consulté
Affichage des données
SDS-PAGE

SARS-CoV-2 Nucleocapsid Protein CTD, His Tag on SDS-PAGE under reducing (R) condition. The gel was stained with Coomassie Blue. The purity of the protein is greater than 95%.
SEC-MALS

The purity of SARS-CoV-2 Nucleocapsid Protein CTD, His Tag (Cat. No. NUN-C5145) is more than 90% and the molecular weight of this protein is around 28-38 kDa verified by SEC-MALS.
Report
Bioactivity-ELISA

Immobilized SARS-CoV-2 Nucleocapsid Protein CTD, His Tag (Cat. No. NUN-C5145) at 1 μg/mL (100 μL/well) can bind Anti-SARS-CoV-2 Nucleocapsid Antibody, Human IgG1 with a linear range of 0.1-2 ng/mL (QC tested).
Protocol
Immobilized SARS-CoV-2 Nucleocapsid Protein CTD, His Tag (Cat. No. NUN-C5145) at 1 μg/mL (100 μL/well) can bind Anti-SARS-CoV-2 Nucleocapsid Antibody, Chimeric mAb, Human IgG1 with a linear range of 0.1-6 ng/mL (Routinely tested).
Protocol
Avis des utilisateurs Publier un commentaire

Introduction de fond
Progrès de frontière
- Nom anglais:
Nucleocapsid proteins
- Catégorie:
- Nombre de médicaments répertoriés:
0 Détails
- Nombre de médicaments cliniques:
2 Détails
- Étape de développement la plus élevée:
Phase 2 Clinical



















